Uncategorized
Investigation Report on Chinese Latanoprost Market, 2018-2022: Basic Concepts, Sales, Major Manufacturers, Prices & Market Prospects – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on Chinese Latanoprost Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. Latanoprost is the first FDA approved prostaglandin for intraocular pressure reduction. In 1999, China began importing Latanoprost as a first-line drug in the clinical treatment of glaucoma. In 2004, Latanoprost eye drops developed by Lunan Better were approved for sale, followed by the products of other domestic manufacturers. And there is a c